Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France.

Lutsyk K, Gicquel T, Cortial L, Forget S, Braun S, Boyer PO, Laugel V, Blin O

Open source

DOI
10.1016/j.therap.2024.01.007
Published
2024 Sep-Oct
Container
Therapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.therap.2024.01.007,
  title = {Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France.},
  author = {Lutsyk K and Gicquel T and Cortial L and Forget S and Braun S and Boyer PO and Laugel V and Blin O},
  year = {2024},
  journal = {Therapie},
  doi = {10.1016/j.therap.2024.01.007},
  url = {https://doi.org/10.1016/j.therap.2024.01.007}
}

RIS

TY  - JOUR
TI  - Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France.
AU  - Lutsyk K
AU  - Gicquel T
AU  - Cortial L
AU  - Forget S
AU  - Braun S
AU  - Boyer PO
AU  - Laugel V
AU  - Blin O
PY  - 2024
JO  - Therapie
DO  - 10.1016/j.therap.2024.01.007
UR  - https://doi.org/10.1016/j.therap.2024.01.007
ER  - 

APA

K, L., T, G., L, C., S, F., S, B., PO, B., V, L., & O, B. (2024). Does gene therapies clinical research in rare diseases reflects the competitivity of the country: Example of France.. Therapie. https://doi.org/10.1016/j.therap.2024.01.007

Source records